India, June 23 -- Primoris Services Corporation (PRIM) shares fell 26.71 percent, losing $28.94 to $79.40 on Tuesday, possibly after the company lowered its 2026 financial outlook yesterday, citing ad... Read More
India, June 23 -- Shares of uniQure N.V. (QURE) are gaining around 6 percent on Tuesday morning, possibly after the company's announcement yesterday about a proposed $150 million underwritten public o... Read More
India, June 23 -- Phathom Pharmaceuticals, Inc. (PHAT), which develops treatments for gastrointestinal diseases, on Tuesday announced that it has completed enrollment in its Phase 2 pHalcon-EoE-201 cl... Read More
India, June 23 -- Boundless Bio, Inc. (BOLD) shares jumped 77.15 percent, gaining $1.08 to $2.4801 on Tuesday, after the company announced a definitive agreement to merge with privately held biotechno... Read More
India, June 23 -- Shares of HeartSciences Inc. (HSCS) are rising about 57 percent in Tuesday morning trading after the company agreed to merge with Fortitude Mining Holdings, Inc.in an all-stock trans... Read More
India, June 23 -- Galectin Therapeutics Inc. (GALT), a clinical-stage biotechnology company, announced that it reached alignment with the U.S. Food and Drug Administration during a recent in-person Ty... Read More
India, June 23 -- Atlantic International Corp. (ATLN) shares surged 138.72 percent, gaining $0.61 to $1.0499 on Tuesday, after the company announced that its Circle8 Group subsidiary, Seven Stars B.V.... Read More
India, June 23 -- After moving sharply lower at the start of trading on Tuesday, stocks have regained some ground over the course of the session. The major averages have climbed well off their worst l... Read More
India, June 23 -- Zeta Global Holdings Corp. (ZETA) shares rose 6.56 percent, gaining $1.21 to $19.66 on Tuesday, after the company announced a strategic partnership with Palantir Technologies to deve... Read More
India, June 23 -- IMUNON, Inc. (IMNN) announced that an independent Data Monitoring Committee has recommended the continuation of the pivotal Phase 3 OVATION 3 trial without any changes, following a s... Read More